Home / National / First-ever phase-three clinical trial for dengue vaccine initiated in India

First-ever phase-three clinical trial for dengue vaccine initiated in India

The indigenous vaccine, DengiAll, has been developed by Panacea Biotec; the phase 3 clinical trial is being conducted by ICMR and the pharma company on over 10,000 participants across 18 States
Share this news

About @click197 - B TELEGRAM BAM 423 751 RUB TINKOFF

Check Also

सीसीआरएच ने किया एएमटीजेड के साथ आपसी सहमति पत्र पर हस्ताक्षर

पिठापुरम । केंद्रीय होम्योपैथी अनुसंधान परिषद, आयुष मंत्रालय, भारत सरकार, नई दिल्ली के महानिदेशक डॉ. …